| # | Drug | Count |
|---|---|---|
| 0 | ZOLEDRONIC ACID | 18 |
| 1 | ALENDRONATE SODIUM | 12 |
| 2 | DENOSUMAB | 12 |
| 3 | ADALIMUMAB | 9 |
| 4 | CAPECITABINE | 9 |
| 5 | ERGOCALCIFEROL | 9 |
| 6 | METHOTREXATE SODIUM | 9 |
| 7 | LETROZOLE | 8 |
| 8 | METHOTREXATE | 8 |
| 9 | OMEPRAZOLE MAGNESIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOREMIFENE CITRATE | 2 | 0.0046 |
| 1 | CEFPROZIL | 1 | 0.0013 |
| 2 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 5 | 0.0011 |
| 3 | DICLOXACILLIN SODIUM | 1 | 0.0011 |
| 4 | SODIUM FLUORIDE AND POTASSIUM NITRATE | 1 | 0.0010 |
| 5 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 6 | FLUNISOLIDE | 1 | 0.0007 |
| 7 | CLINDAMYCIN PHOSPHATE | 3 | 0.0005 |
| 8 | BACITRACIN | 2 | 0.0005 |
| 9 | ANIFROLUMAB-FNIA | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 1 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 2 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Cannabinoid [EPC] | 2 | 0.0002 |
| 4 | Antiseptic [EPC] | 1 | 0.0002 |
| 5 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Aromatase Inhibitor [EPC] | 15 | 0.0001 |
| 8 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Androgen Receptor Inhibitor [EPC] | 7 | 0.0001 |